mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects von Witkin, Jeffrey M.

Volltext

Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement von Witkin, Jeffrey M, Lippa, Arnold

Volltext

The romantic age of pharmacological science von Witkin, Jeffrey M.

Volltext

ANXIOLYTICS: Origins, drug discovery, and mechanisms von Witkin, Jeffrey M., Barrett, James E.

Volltext

Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications? von Witkin, Jeffrey M., Shafique, Hana, Smith, Jodi L., Cerne, Rok

Volltext

GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors von Cerne, Rok, Lippa, Arnold, Poe, Michael M., Smith, Jodi L., Jin, Xiaoming, Ping, Xingjie, Golani, Lalit K., Cook, James M., Witkin, Jeffrey M.

Volltext

ANXIOLYTICS: Introduction to a special issue celebrating 50 years of Pharmacology, Biochemistry and Behavior von Witkin, Jeffrey M., Barrett, James E.

Volltext

Clinical investigations of compounds targeting metabotropic glutamate receptors von Witkin, Jeffrey M., Pandey, Kamal P., Smith, Jodi L.

Volltext

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms von Zanos, Panos, Moaddel, Ruin, Morris, Patrick J, Riggs, Lace M, Highland, Jaclyn N, Georgiou, Polymnia, Pereira, Edna F R, Albuquerque, Edson X, Thomas, Craig J, Zarate, Jr, Carlos A, Gould, Todd D

Volltext

High Impact AMPAkines Induce a Gq‐Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkines von Radin, Daniel P., Zhong, Sheng, Cerne, Rok, Witkin, Jeffrey M., Lippa, Arnold

Volltext

Synthesis of (−)-11‑O‑Debenzoyltashironin: Neurotrophic Sesquiterpenes Cause Hyperexcitation von Ohtawa, Masaki, Krambis, Michael J, Cerne, Rok, Schkeryantz, Jeffrey M, Witkin, Jeffrey M, Shenvi, Ryan A

Volltext

Trace Amines and Their Receptors von Gainetdinov, Raul R, Hoener, Marius C, Berry, Mark D

Volltext

The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis von Scofield, M D, Heinsbroek, J A, Gipson, C D, Kupchik, Y M, Spencer, S, Smith, A C W, Roberts-Wolfe, D, Kalivas, P W

Volltext

The biology of Nociceptin/Orphanin FQ(N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence von WITKIN, Jeffrey M, STATNICK, Michael A, RORICK-KEHN, Linda M, PINTAR, John E, ANSONOFF, Michael, YANYUN CHEN, TUCKER, R. Craig, CICCOCIOPPO, Roberto

Volltext

Prediction of human efficacious antidepressant doses using the mouse forced swim test von Yuen, Eunice, Swanson, Steven, Witkin, Jeffrey M.

Volltext

( R )-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders von Shafique, Hana, Demers, Julie C, Biesiada, Julia, Golani, Lalit K, Cerne, Rok, Smith, Jodi L, Szostak, Marta, Witkin, Jeffrey M

Volltext

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders von Rorick-Kehn, Linda M., Witkin, Jeffrey M., Statnick, Michael A., Eberle, Elizabeth L., McKinzie, Jamie H., Kahl, Steven D., Forster, Beth M., Wong, Conrad J., Li, Xia, Crile, Robert S., Shaw, David B., Sahr, Allison E., Adams, Benjamin L., Quimby, Steven J., Diaz, Nuria, Jimenez, Alma, Pedregal, Concepcion, Mitch, Charles H., Knopp, Kelly L., Anderson, Wesley H., Cramer, Jeffrey W., McKinzie, David L.

Volltext

Mood disorders: Regulation by metabotropic glutamate receptors von Pilc, Andrzej, Chaki, Shigeyuki, Nowak, Gabriel, Witkin, Jeffrey M.

Volltext

Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy von Rana, Sabhya, Fusco, Anna F., Witkin, Jeffrey M., Radin, Daniel P., Cerne, Rok, Lippa, Arnold, Fuller, David D.

Volltext

The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders von Witkin, Jeffrey M., Lippa, Arnold, Smith, Jodi L., Jin, Xiaoming, Ping, Xingjie, Biggerstaff, Andrew, Kivell, Bronwyn M., Knutson, Daniel E., Sharmin, Dishary, Pandey, Kamal P., Mian, Md Yeunus, Cook, James M., Cerne, Rok

Volltext